Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.120
+0.010 (0.47%)
At close: Aug 11, 2026, 4:00 PM EDT
2.140
+0.020 (0.94%)
Pre-market: Aug 12, 2026, 9:19 AM EDT
Grace Therapeutics Market Cap
Grace Therapeutics has a market cap or net worth of $44.6 million as of August 12, 2026. Its market cap has increased by 0.22% in one year.
Market Cap
44.60M
Enterprise Value
27.62M
1-Year Change
0.22%
Ranking
Category
Stock Price
$2.12
ChartMarket Cap Chart
Since January 9, 2015, Grace Therapeutics's market cap has decreased from $6.81B to $44.60M, a decrease of -99.35%. That is a compound annual growth rate of -35.19%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 34.50M | -29.45% |
| Dec 31, 2025 | 48.90M | 29.02% |
| Dec 31, 2024 | 37.90M | 39.34% |
| Dec 29, 2023 | 27.20M | 21.43% |
| Dec 30, 2022 | 22.40M | -59.86% |
| Dec 31, 2021 | 55.80M | 77.14% |
| Dec 31, 2020 | 31.50M | -84.91% |
| Dec 31, 2019 | 208.70M | 584.26% |
| Dec 31, 2018 | 30.50M | 119.42% |
| Dec 29, 2017 | 13.90M | 3.73% |
| Dec 30, 2016 | 13.40M | -99.80% |
| Jan 9, 2015 | 6.81B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Veraxa Biotech AG | 47.66M |
| Karyopharm Therapeutics | 47.59M |
| Filana Therapeutics | 46.94M |
| Impact BioMedical | 46.36M |
| Seres Therapeutics | 46.13M |
| Metagenomi Therapeutics | 45.55M |
| Aligos Therapeutics | 45.46M |
| Veru Inc. | 44.78M |